HysensBio Co., Ltd
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 2 Study of KH001 in Long-term Relief From Dentin Hypersensitivity (NCT06464939) | HysensBio Co., Ltd | 2024-10-08 |
| A Study to Evaluate the Efficacy and Safety of KH001 in Patients with Dentin Hypersensitivity (NCT06264453) | HysensBio Co., Ltd | 2024-03-19 |
| Evaluation of the Safety and Tolerability of KH001 in Dentin Hypersensitivity Patients (NCT04804514) | HysensBio Co., Ltd | 2021-06-14 |
Track HysensBio Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.